Lupin informs about press release

08 Jun 2020 Evaluate

Lupin has informed that the Company enclosed a Press Release regarding grant of Orphan Drug Designation by US FDA to mexiletine hydrochloride for the treatment of myotonic disorders.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2089.65 -0.50 (-0.02%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×